• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

4-喹诺酮类抗菌药物的体外比较研究。

Comparative in vitro studies with 4-quinolone antimicrobials.

作者信息

Felmingham D, O'Hare M D, Robbins M J, Wall R A, Williams A H, Cremer A W, Ridgway G L, Grüneberg R N

出版信息

Drugs Exp Clin Res. 1985;11(5):317-29.

PMID:2941259
Abstract

The minimal inhibitory concentrations (MICs) of nalidixic acid, pipemidic acid, cinoxacin, oxolinic acid, flumequine, pefloxacin, acrosoxacin, amifloxacin, norfloxacin, enoxacin, ofloxacin and ciprofloxacin were determined for a range of clinical isolates. MICs were determined using an agar dilution technique in Mueller-Hinton agar supplemented with 10% lysed horse blood. The inoculum used was approximately 10(4) colony forming units, contained in 10 microliters Mueller-Hinton broth, which was applied to the agar plates using a multipoint inoculator. Following inoculation, plates were incubated in conditions appropriate for the organisms under investigation. The MIC of each antimicrobial for each isolate examined was determined as the lowest concentration of the antimicrobial which completely inhibited growth of the inoculum. The minimum concentrations required to inhibit the growth of 50% (MIC50) and 90% (MIC90) of the organisms examined were also determined. All of the more recently synthesised 4-quinolones showed considerably greater activity than the parent compounds, nalidixic acid, pipemidic acid and cinoxacin, against the range of organisms used in this study. Ciprofloxacin and ofloxacin were the two most active of the 4-quinolones examined.

摘要

测定了一系列临床分离株对萘啶酸、吡哌酸、西诺沙星、恶喹酸、氟甲喹、培氟沙星、阿克罗沙星、阿米氟沙星、诺氟沙星、依诺沙星、氧氟沙星和环丙沙星的最低抑菌浓度(MIC)。MIC采用琼脂稀释法在补充有10%溶血马血的穆勒-欣顿琼脂中测定。使用的接种物约为10⁴ 个菌落形成单位,包含在10微升穆勒-欣顿肉汤中,用多点接种器将其接种到琼脂平板上。接种后,将平板在适合所研究微生物的条件下培养。所检测的每种抗菌药物对每个分离株的MIC被确定为完全抑制接种物生长的抗菌药物的最低浓度。还测定了抑制所检测微生物50%(MIC50)和90%(MIC90)生长所需的最低浓度。在本研究中使用的一系列微生物中,所有最近合成的4-喹诺酮类药物均显示出比母体化合物萘啶酸、吡哌酸和西诺沙星显著更高的活性。环丙沙星和氧氟沙星是所检测的4-喹诺酮类药物中活性最强的两种。

相似文献

1
Comparative in vitro studies with 4-quinolone antimicrobials.4-喹诺酮类抗菌药物的体外比较研究。
Drugs Exp Clin Res. 1985;11(5):317-29.
2
The comparative activity of twelve 4-quinolone antimicrobials against Haemophilus influenzae and Streptococcus pneumoniae.十二种4-喹诺酮类抗菌药物对流感嗜血杆菌和肺炎链球菌的比较活性。
Drugs Exp Clin Res. 1985;11(4):259-62.
3
The comparative in vitro activity of twelve 4-quinolone antimicrobials against enteric pathogens.十二种4-喹诺酮类抗菌药物对肠道病原体的体外活性比较
Drugs Exp Clin Res. 1985;11(4):253-7.
4
Frequency and expression of mutational resistance to the 4-quinolone antibacterials.对4-喹诺酮类抗菌药物的突变耐药性的频率和表达
Scand J Infect Dis Suppl. 1986;49:115-23.
5
[Comparison of the in vitro activity of 6 quinolones on Pseudomonas sp].6种喹诺酮类药物对假单胞菌属的体外活性比较
Pathol Biol (Paris). 1985 May;33(5):412-5.
6
[In vitro activity of new quinolones against Mycoplasma pathogenic to humans].新型喹诺酮类药物对人致病性支原体的体外活性
Pathol Biol (Paris). 1988 May;36(5):496-9.
7
The comparative activity of twelve 4-quinolone antimicrobials against gram-positive and gram-negative anaerobes.
Drugs Exp Clin Res. 1985;11(7):431-4.
8
The comparative activity of twelve 4-quinolone antimicrobials and sulphadiazine against Neisseria meningitidis.
Drugs Exp Clin Res. 1985;11(7):427-9.
9
Comparative antimicrobial activity of enoxacin, ciprofloxacin, amifloxacin, norfloxacin and ofloxacin against 177 bacterial isolates.依诺沙星、环丙沙星、阿米氟沙星、诺氟沙星和氧氟沙星对177株细菌分离株的抗菌活性比较
J Antimicrob Chemother. 1986 May;17(5):623-8. doi: 10.1093/jac/17.5.623.
10
[Comparative in vitro effect of 7 quinolones on Ureaplasma urealyticum].7种喹诺酮类药物对解脲脲原体的体外比较作用
Pathol Biol (Paris). 1983 Jun;31(6):501-3.

引用本文的文献

1
A review on the development of urease inhibitors as antimicrobial agents against pathogenic bacteria.脲酶抑制剂作为抗病原菌抗菌剂的发展综述。
J Adv Res. 2018 May 4;13:69-100. doi: 10.1016/j.jare.2018.05.003. eCollection 2018 Sep.
2
Oral Bioavailability and Plasma Disposition of Pefloxacin in Healthy Broiler Chickens.培氟沙星在健康肉鸡中的口服生物利用度及血浆处置情况
Front Vet Sci. 2017 May 24;4:77. doi: 10.3389/fvets.2017.00077. eCollection 2017.
3
Synthesis of New Nitrofluoroquinolone Derivatives with Novel Anti-Microbial Properties against Metronidazole Resistant H. pylori.
具有抗甲硝唑耐药幽门螺杆菌新抗菌特性的新型硝基氟喹诺酮衍生物的合成
Molecules. 2017 Jan 4;22(1):71. doi: 10.3390/molecules22010071.
4
Heterocycles [h]-fused onto 4-oxoquinoline-3-carboxylic acid, part VIII [1]. Convenient synthesis and antimicrobial properties of substituted hexahydro[1,4]diazepino[2,3-h]quinoline-9-carboxylic acid and its tetrahydroquino[7,8-b]benzodiazepine analog.稠合在4-氧代喹啉-3-羧酸上的杂环化合物[h],第八部分[1]。取代的六氢[1,4]二氮杂卓并[2,3-h]喹啉-9-羧酸及其四氢喹啉并[7,8-b]苯并二氮杂卓类似物的简便合成与抗菌性能
Molecules. 2008 Nov 18;13(11):2880-93. doi: 10.3390/molecules13112880.
5
Heterocycles [h]fused onto 4-oxoquinoline-3-carboxylic acid, part IV. Convenient synthesis of substituted hexahydro [1,4]thiazepino[2,3-h]quinoline-9-carboxylic acid and its tetrahydroquino[7,8-b]benzothiazepine homolog.稠合于4-氧代喹啉-3-羧酸上的杂环[h],第四部分。取代的六氢[1,4]噻氮杂卓并[2,3-h]喹啉-9-羧酸及其四氢喹啉并[7,8-b]苯并噻嗪同系物的简便合成。
Molecules. 2007 Jul 27;12(8):1558-68. doi: 10.3390/12081558.
6
Synthesis and antibacterial properties of new 8-nitrofluoroquinolone derivatives.新型8-硝基氟喹诺酮衍生物的合成及其抗菌性能
Molecules. 2007 Jun 30;12(6):1240-58. doi: 10.3390/12061240.
7
Canadian ciprofloxacin susceptibility study: comparative study from 15 medical centers. Canadian Ciprofloxacin Study Group.加拿大环丙沙星敏感性研究:来自15个医学中心的比较研究。加拿大环丙沙星研究小组。
Antimicrob Agents Chemother. 1996 Jul;40(7):1729-32. doi: 10.1128/AAC.40.7.1729.
8
Penetration of ciprofloxacin into human lung tissue following intravenous injection.静脉注射后环丙沙星在人肺组织中的渗透情况。
Infection. 1986 Nov-Dec;14(6):299-300. doi: 10.1007/BF01643967.
9
[Enoxacin: spectrum and activity of its antibacterial effect].[依诺沙星:其抗菌作用的谱与活性]
Infection. 1986;14 Suppl 3:S188-90. doi: 10.1007/BF01667841.
10
Fluorinated quinolones. A review of their mode of action, antimicrobial activity, pharmacokinetics and clinical efficacy.氟喹诺酮类。对其作用方式、抗菌活性、药代动力学及临床疗效的综述。
Pharm Weekbl Sci. 1986 Feb 21;8(1):1-21. doi: 10.1007/BF01975473.